相关实验视频

Updated: Jan 17, 2026

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

Published on: September 12, 2019

淋巴切除术可以预测早期的上皮卵巢癌的存活率吗? 一个更新的系统审查和元分析

Yan Jin¹, Chaoyou Zhou²

¹Yan Jin Department of Gynaecology, Huzhou Maternity & Child Health Care Hospital, Huzhou City, Zhejiang Province 313000, P.R. China.

Pakistan journal of medical sciences

|September 22, 2025

概括

淋巴切除术可以改善早期上皮卵巢癌 (EOC) 的存活率. 这项对24项研究的最新审查发现,接受该程序的患者的整体存活率 (OS) 和无进展存活率 (PFS) 更好.

科学领域:

在瘤学瘤学.
妇科瘤学妇科瘤学
手术瘤学手术瘤学

背景情况:

淋巴切除术在早期卵巢上皮癌 (eEOC) 中的作用仍然是争论的主题.
现有的系统性审查在研究范围和数量方面是有限的.
本研究提供了最新的元分析,以澄清淋巴切除术对eEOC生存结果的影响.

研究的目的:

评估淋巴切除术对早期上皮卵巢癌 (eEOC) 患者的整体生存期 (OS) 和无进展生存期 (PFS) 的影响.
通过更新的系统审查和元分析,综合综合综合一系列研究的证据.

主要方法:

在PubMed,PubMed CENTRAL,Embase和Web of Science数据库中进行了系统的搜索.
包括24项报告基于淋巴切除术的eEOC调整结果的研究.
使用随机效应元分析,子组分析和元回归来分析数据.

主要成果:

对20项研究的元分析显示,在接受淋巴切除术的患者中,显著改善了OS (HR:0.808),13项研究显示显著改善了PFS (HR:0.743).
敏感性分析证实了这些估计的稳定性.
超回归表明淋巴结转移和化疗使用并没有显著影响观察到的生存益处.

结论:

淋巴切除术似乎与早期的上皮卵巢癌中改善的OS和PFS有关.
显著的局限性包括许多包含的研究的回顾性和它们之间的异质性,需要谨慎的解释.
登记名:PROSPERO (CRD420250656184) 这是一款

关键词:

淋巴结解剖淋巴结的解剖死亡率死亡率死亡率卵巢癌是发生在卵巢的癌症.复发复发的情况进行分期,分期.

更多相关视频

Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy

Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy

Published on: August 19, 2021

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

相关概念视频

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...